RB1 and prostate cancer: This binding induces transforming growth factor-β receptor-III (TGFβRIII) to activate phospho-p38MAPK, which phosphorylates retinoblastoma (Rb) protein and blocks prostate cancer cell proliferation by upregulating p27.